Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- 31 May 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 9 (5), 481-488
- https://doi.org/10.1016/s1474-4422(10)70068-5
Abstract
No abstract availableKeywords
Funding Information
- Amyotrophic Lateral Sclerosis Association
- ALS Society of Canada
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
This publication has 21 references indexed in Scilit:
- Lithium enhances the neuronal differentiation of neural progenitor cellsin vitroand after transplantation into the avulsed ventral horn of adult rats through the secretion of brain‐derived neurotrophic factorJournal of Neurochemistry, 2009
- Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse modelNeuroscience, 2008
- Lithium delays progression of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2008
- Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative diseaseThe Journal of cell biology, 2007
- Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cordExperimental Neurology, 2007
- Concurrent Administration of Neu2000 and Lithium Produces Marked Improvement of Motor Neuron Survival, Motor Function, and Mortality in a Mouse Model of Amyotrophic Lateral SclerosisMolecular Pharmacology, 2006
- Trial of celecoxib in amyotrophic lateral sclerosisAnnals of Neurology, 2006
- Lithium induces autophagy by inhibiting inositol monophosphataseThe Journal of cell biology, 2005
- Rating the severity of ALS by caregivers over the telephone using the ALSFRS‐RAmyotrophic Lateral Sclerosis, 2005
- The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluationPsychological Medicine, 2004